Stay updated on PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo

Sign up to get notified when there's something new on the PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo page.
Latest website image capture
Clouds background image

Latest updates to the PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the previous funding notice and Revision: v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-11T11:35:58.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide notice about government funding status was added, advising users to check cc.nih.gov and opm.gov for updates. The page version was updated to Revision: v3.4.1, replacing v3.4.0.
    Difference
    0.3%
    Check dated 2026-02-04T10:26:29.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Glossary toggle added and study-record metadata labels updated (including capitalization tweaks to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data') with Revision: v3.4.0. No core content, outcomes, or eligibility criteria were changed.
    Difference
    0.2%
    Check dated 2026-01-28T05:56:20.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:47:02.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added a comprehensive list of study locations across the United States and abroad (including numerous US states and international regions) and updated the document revision to v3.3.3.
    Difference
    2%
    Check dated 2025-12-23T21:42:38.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Study status changed from Active, not recruiting to Completed; enrollment updated from 120 (Estimated) to 102 (Actual), with related dates adjusted accordingly.
    Difference
    0.4%
    Check dated 2025-12-02T16:43:10.000Z thumbnail image

Stay in the know with updates to PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo

Enter your email address, and we'll notify you when there's something new on the PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo page.